Xiaofeng Qian

3.0k total citations · 1 hit paper
33 papers, 2.2k citations indexed

About

Xiaofeng Qian is a scholar working on Hepatology, Surgery and Oncology. According to data from OpenAlex, Xiaofeng Qian has authored 33 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 11 papers in Surgery and 7 papers in Oncology. Recurrent topics in Xiaofeng Qian's work include Organ Transplantation Techniques and Outcomes (7 papers), Liver Disease and Transplantation (6 papers) and Liver physiology and pathology (5 papers). Xiaofeng Qian is often cited by papers focused on Organ Transplantation Techniques and Outcomes (7 papers), Liver Disease and Transplantation (6 papers) and Liver physiology and pathology (5 papers). Xiaofeng Qian collaborates with scholars based in China, United States and South Korea. Xiaofeng Qian's co-authors include Xue Han, Edward S. Boyden, Gabriel M. Belfort, Allison S. Dobry, Yingxi Lin, Brian Y. Chow, Patrick E. Monahan, Amy S. Chuong, Mingjie Li and Michael Henninger and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Neuron.

In The Last Decade

Xiaofeng Qian

31 papers receiving 2.1k citations

Hit Papers

High-performance genetically targetable optical neural si... 2010 2026 2015 2020 2010 250 500 750

Peers

Xiaofeng Qian
Fei Yi United States
Janie Baratta United States
Thomas Ott Germany
Xiaofeng Qian
Citations per year, relative to Xiaofeng Qian Xiaofeng Qian (= 1×) peers Maura Castagna

Countries citing papers authored by Xiaofeng Qian

Since Specialization
Citations

This map shows the geographic impact of Xiaofeng Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Qian more than expected).

Fields of papers citing papers by Xiaofeng Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Qian. The network helps show where Xiaofeng Qian may publish in the future.

Co-authorship network of co-authors of Xiaofeng Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Qian. A scholar is included among the top collaborators of Xiaofeng Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Qian. Xiaofeng Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Dan, Wei Yu, Yating Zheng, et al.. (2025). Transmembrane BAX inhibitor motif containing 1 inhibition of lysosomal degradation of TGF-β receptor 1 suppresses cellular senescence and hepatocarcinogenesis. Journal of Biological Chemistry. 301(12). 110904–110904.
2.
Tao, Min, Dan Zhou, Luyao Zhang, et al.. (2025). Lipopolysaccharide Induces Resistance to CAR-T Cell Therapy of Colorectal Cancer Cells through TGF-β-Mediated Stemness Enhancement. Molecular Pharmaceutics. 22(4). 1790–1803. 5 indexed citations
3.
Zhang, Liren, Jiali Xu, Ruizhi Zhang, et al.. (2023). Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma. Journal of Hepatology. 80(1). 82–98. 81 indexed citations
4.
Dai, Xinzheng, Yong Shi, Xiaowen Zhu, et al.. (2021). CHI3L1 alleviate acute liver injury by inhibiting Th1 cells differentiation through STAT3 signaling pathway. Annals of Translational Medicine. 9(7). 529–529. 6 indexed citations
5.
Wu, Chen, Lei Deng, Han Zhuo, et al.. (2020). Circulating circRNA predicting the occurrence of hepatocellular carcinoma in patients with HBV infection. Journal of Cellular and Molecular Medicine. 24(17). 10216–10222. 26 indexed citations
6.
Li, Guoqiang, Xiaoxin Mu, Xinli Huang, et al.. (2017). Liver transplantation using the otherwise-discarded partial liver resection graft with hepatic benign tumor. Medicine. 96(29). e7295–e7295. 5 indexed citations
7.
Rao, Jianhua, Feng Zhang, Lu Hao, et al.. (2017). Effects of multimodal fast-track surgery on liver transplantation outcomes. Hepatobiliary & pancreatic diseases international. 16(4). 364–369. 24 indexed citations
8.
Fan, Ye, Xiaofeng Qian, & Chuanyong Zhang. (2016). U/G SNP rs111904020 in 3′UTR of STAT3 regulated by miR-214 promotes hepatocellular carcinoma development in Chinese population. Tumor Biology. 37(11). 14629–14635. 9 indexed citations
9.
Rao, Jianhua, Haoming Zhou, Guoqiang Li, et al.. (2014). Remain recipient partial liver during liver transplant after Hassab. Journal of Surgical Research. 189(2). 321–325. 3 indexed citations
10.
Rao, Jianhua, Jianjie Qin, Xiaofeng Qian, et al.. (2013). Lipopolysaccharide Preconditioning Protects Hepatocytes from Ischemia/Reperfusion Injury (IRI) through Inhibiting ATF4-CHOP Pathway in Mice. PLoS ONE. 8(6). e65568–e65568. 47 indexed citations
11.
Tan, Zhongming, Xiaofeng Qian, Runqiu Jiang, et al.. (2013). IL-17A Plays a Critical Role in the Pathogenesis of Liver Fibrosis through Hepatic Stellate Cell Activation. The Journal of Immunology. 191(4). 1835–1844. 272 indexed citations
12.
Rao, Jianhua, Min Feng, Xiaofeng Qian, et al.. (2013). Liver transplantation treating the patient with hepatic failure associated with sorafenib treatment: report of a case.. PubMed. 60(126). 1317–9. 4 indexed citations
13.
Rao, Jianhua, Xiaofeng Qian, Ping Wang, et al.. (2012). All-trans retinoic acid preconditioning protects against liver ischemia/reperfusion injury by inhibiting the nuclear factor kappa B signaling pathway. Journal of Surgical Research. 180(2). e99–e106. 37 indexed citations
14.
Feng, Min, et al.. (2012). IL-17A-producing NK cells were implicated in liver injury induced by ischemia and reperfusion. International Immunopharmacology. 13(2). 135–140. 38 indexed citations
15.
Lingala, Shilpa, Yiyao Cui, Xiaoli Chen, et al.. (2010). Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Experimental and Molecular Pathology. 89(1). 27–35. 97 indexed citations
16.
Chow, Brian Y., Xue Han, Allison S. Dobry, et al.. (2010). High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature. 463(7277). 98–102. 875 indexed citations breakdown →
17.
Han, Xue, Xiaofeng Qian, Jacob Bernstein, et al.. (2009). Millisecond-Timescale Optical Control of Neural Dynamics in the Nonhuman Primate Brain. DSpace@MIT (Massachusetts Institute of Technology). 8 indexed citations
18.
Han, Xue, Xiaofeng Qian, Jacob Bernstein, et al.. (2009). Millisecond-Timescale Optical Control of Neural Dynamics in the Nonhuman Primate Brain. Neuron. 62(2). 191–198. 358 indexed citations
19.
Yu, Yue, Ling Lü, Xiaofeng Qian, et al.. (2009). Antifibrotic Effect of Hepatocyte Growth Factor-Expressing Mesenchymal Stem Cells in Small-for-Size Liver Transplant Rats. Stem Cells and Development. 19(6). 903–914. 52 indexed citations
20.
Cheng, Feng, Guoqiang Li, Feng Zhang, et al.. (2009). Outcomes of Living-Related Liver Transplantation for Wilson’s Disease: A Single-Center Experience in China. Transplantation. 87(5). 751–757. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026